METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis

Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA

(2022) Li Zhou et al.   Molecular Cancer

Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer

(2021) Bela Goyal et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review

(2021) Carmine Conte et al.   Annals of Translational Medicine

METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma

(2021) Yu-Zhou Chang et al.   CANCER LETTERS

ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer

(2021) Sipei Nie et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

tRNA-like leader-trailer interaction promotes 3′-end maturation of MALAT1

(2021) Seyed-Fakhreddin Torabi et al.   RNA

A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer

(2021) Qian Li et al.   Frontiers in Cell and Developmental Biology

METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246

(2021) Xuehan Bi et al.   Cell Death Discovery

LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment

(2021) Tsui-Lien Mao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer

(2020) Huilin Huang et al.   CANCER CELL

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma

(2020) Roman E. Zyla et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer

(2020) Jing Wang et al.   Journal of Ovarian Research

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma

(2020) Pei Wang et al.   Frontiers in Genetics

Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors

(2020) Kai Li et al.   Aging-US

Ovarian Cancer: An Integrated Review

(2019) Christine Stewart et al.   Seminars in Oncology Nursing

A highly ordered, non-protective MALAT1 ENE structure is adopted prior to triplex formation.

(2019) Michael J Yonkunas et al.   RNA

Ovarian cancer statistics, 2018

(2018) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m 6 A Modification

(2018) Hengyou Weng et al.   Cell Stem Cell

Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development

(2018) Mateusz Mendel et al.   MOLECULAR CELL

mRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis

(2018) Junho Choe et al.   NATURE

Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA

(2016) Jessica A. Brown et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

(2016) Marios Giannakis et al.   Cell Reports